Level Four Advisory Services LLC Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Level Four Advisory Services LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,124 shares of the exchange traded fund’s stock after selling 223 shares during the period. Level Four Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $552,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Golden State Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $29,000. Avior Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $43,000.

SPDR S&P Biotech ETF Trading Down 1.3 %

XBI stock opened at $84.40 on Monday. The company’s 50 day moving average is $89.40 and its 200 day moving average is $93.91. The stock has a market cap of $5.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.